Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ABX-001 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on ABX-001, a putative optimized arenavirus vector with tumor-tropic mutations (Nov 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ABX-001 | ABX 001|ABX001 | Limited information is currently available on ABX-001, a putative optimized arenavirus vector with tumor-tropic mutations (Nov 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07231458 | Phase I | ABX-001 ABX-001 + Pembrolizumab | A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies | Recruiting | ESP | 0 |